Hexagon Capital Partners’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-254
| Closed | -$21.8K | – | 1243 |
|
|
2025
Q1 | $21.8K | Buy |
254
+71
| +39% | +$6.1K | ﹤0.01% | 727 |
|
|
2024
Q4 | $14.3K | Buy |
183
+22
| +14% | +$1.72K | ﹤0.01% | 899 |
|
|
2024
Q3 | $11.6K | Buy |
161
+25
| +18% | +$1.8K | ﹤0.01% | 875 |
|
|
2024
Q2 | $9.36K | Sell |
136
-10
| -7% | -$689 | ﹤0.01% | 893 |
|
|
2024
Q1 | $10.6K | Sell |
146
-7
| -5% | -$508 | ﹤0.01% | 846 |
|
|
2023
Q4 | $9.37K | Sell |
153
-17
| -10% | -$1.04K | ﹤0.01% | 843 |
|
|
2023
Q3 | $9.72K | Buy |
170
+42
| +33% | +$2.4K | ﹤0.01% | 755 |
|
|
2023
Q2 | $7.61K | Sell |
128
-16
| -11% | -$951 | ﹤0.01% | 812 |
|
|
2023
Q1 | $9.02K | Sell |
144
-45
| -24% | -$2.82K | ﹤0.01% | 754 |
|
|
2022
Q4 | $11.8K | Buy |
189
+6
| +3% | +$376 | ﹤0.01% | 678 |
|
|
2022
Q3 | $9K | Buy |
183
+131
| +252% | +$6.44K | ﹤0.01% | 800 |
|
|
2022
Q2 | $3K | Buy |
+52
| New | +$3K | ﹤0.01% | 909 |
|